{"entity":{"type":"insider","cik":"0001272353","url":"/insider/0001272353","json_url":"/insider/0001272353.json","name":"LAWRENCE DAVID","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":312,"n_filings":54,"first":"2006-11-08","last":"2019-12-04","span_basis":"filed_date"},"name_variants":[{"name":"LAWRENCE DAVID","source":"filing","n_filings":54,"first_seen":"2006-11-08","last_seen":"2019-12-04"}],"transactions":[{"id":8030018,"accession":"0001209191-19-058937","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-058937","line_url":"/filing/0001209191-19-058937#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief, Bus. Ops & PAO)","role_mark":"O","role_mark_label":"Officer (Chief, Bus. Ops & PAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief, Bus. Ops & PAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1176.0,"shares_display":"1,176","price_per_share":1.5986,"price_display":"1.60","price_state":"stated","total_value":1879.9536,"total_display":"1,879.95","total_whole":"1,880","shares_owned_after":12961.0,"shares_owned_after_display":"12,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-04","scope":"insider"},{"id":8597242,"accession":"0001209191-19-012973","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-012973","line_url":"/filing/0001209191-19-012973#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief, Bus. Ops & PAO)","role_mark":"O","role_mark_label":"Officer (Chief, Bus. Ops & PAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief, Bus. Ops & PAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":761.0,"shares_display":"761","price_per_share":13.1778,"price_display":"13.18","price_state":"stated","total_value":10028.3058,"total_display":"10,028.31","total_whole":"10,028","shares_owned_after":5092.0,"shares_owned_after_display":"5,092","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-22","filed_date":"2019-02-25","scope":"insider"},{"id":6635620,"accession":"0001209191-18-061106","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-061106","line_url":"/filing/0001209191-18-061106#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief, Bus. Ops & PAO)","role_mark":"O","role_mark_label":"Officer (Chief, Bus. Ops & PAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief, Bus. Ops & PAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2493.0,"shares_display":"2,493","price_per_share":20.5504,"price_display":"20.55","price_state":"stated","total_value":51232.1472,"total_display":"51,232.15","total_whole":"51,232","shares_owned_after":3653.0,"shares_owned_after_display":"3,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider"},{"id":6764393,"accession":"0001209191-18-037359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-037359","line_url":"/filing/0001209191-18-037359","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief, Bus. Ops & PAO)","role_mark":"O","role_mark_label":"Officer (Chief, Bus. Ops & PAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief, Bus. Ops & PAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3431.0,"shares_display":"3,431","price_per_share":31.741262314194113,"price_display":"31.74","price_state":"stated","total_value":108904.271,"total_display":"108,904.27","total_whole":"108,904","shares_owned_after":4993.0,"shares_owned_after_display":"4,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-12","filed_date":"2018-06-13","scope":"insider","n_lines":2},{"id":6200334,"accession":"0001209191-18-036828","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-18-036828","line_url":"/filing/0001209191-18-036828","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief, Bus. Ops & PAO)","role_mark":"O","role_mark_label":"Officer (Chief, Bus. Ops & PAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief, Bus. Ops & PAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5120.0,"shares_display":"5,120","price_per_share":28.8685546875,"price_display":"28.87","price_state":"stated","total_value":147807.0,"total_display":"147,807.00","total_whole":"147,807","shares_owned_after":9244.0,"shares_owned_after_display":"9,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-11","scope":"insider","n_lines":5},{"id":6200307,"accession":"0001209191-18-036828","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-036828","line_url":"/filing/0001209191-18-036828#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief, Bus. Ops & PAO)","role_mark":"O","role_mark_label":"Officer (Chief, Bus. Ops & PAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief, Bus. Ops & PAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19880.0,"shares_display":"19,880","price_per_share":28.0169,"price_display":"28.02","price_state":"stated","total_value":556975.972,"total_display":"556,975.97","total_whole":"556,976","shares_owned_after":8124.0,"shares_owned_after_display":"8,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-07","filed_date":"2018-06-11","scope":"insider"},{"id":6286183,"accession":"0001209191-18-004680","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-004680","line_url":"/filing/0001209191-18-004680","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief, Bus. Ops & PAO)","role_mark":"O","role_mark_label":"Officer (Chief, Bus. Ops & PAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief, Bus. Ops & PAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30418.0,"shares_display":"30,418","price_per_share":27.58882243408508,"price_display":"27.59","price_state":"stated","total_value":839196.8008,"total_display":"839,196.80","total_whole":"839,197","shares_owned_after":5193.0,"shares_owned_after_display":"5,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-19","filed_date":"2018-01-22","scope":"insider","n_lines":2},{"id":6286170,"accession":"0001209191-18-004680","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-004680","line_url":"/filing/0001209191-18-004680#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief, Bus. Ops & PAO)","role_mark":"O","role_mark_label":"Officer (Chief, Bus. Ops & PAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief, Bus. Ops & PAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":582.0,"shares_display":"582","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":15714.0,"total_display":"15,714.00","total_whole":"15,714","shares_owned_after":4693.0,"shares_owned_after_display":"4,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-18","filed_date":"2018-01-22","scope":"insider"},{"id":4837945,"accession":"0001209191-17-063697","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-063697","line_url":"/filing/0001209191-17-063697#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief, Bus. Ops & PAO)","role_mark":"O","role_mark_label":"Officer (Chief, Bus. Ops & PAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief, Bus. Ops & PAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3993.0,"shares_display":"3,993","price_per_share":20.5072,"price_display":"20.51","price_state":"stated","total_value":81885.2496,"total_display":"81,885.25","total_whole":"81,885","shares_owned_after":4693.0,"shares_owned_after_display":"4,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider"},{"id":5210248,"accession":"0001209191-17-056617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-056617","line_url":"/filing/0001209191-17-056617#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief, Bus. Ops & PAO)","role_mark":"O","role_mark_label":"Officer (Chief, Bus. Ops & PAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief, Bus. Ops & PAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":25.4,"price_display":"25.40","price_state":"stated","total_value":6350.0,"total_display":"6,350.00","total_whole":"6,350","shares_owned_after":8686.0,"shares_owned_after_display":"8,686","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-09","filed_date":"2017-10-11","scope":"insider"},{"id":4933737,"accession":"0001209191-17-009973","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-009973","line_url":"/filing/0001209191-17-009973#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief, Bus. Ops & PAO)","role_mark":"O","role_mark_label":"Officer (Chief, Bus. Ops & PAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief, Bus. Ops & PAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63183.0,"shares_display":"63,183","price_per_share":22.3247,"price_display":"22.32","price_state":"stated","total_value":1410541.5201,"total_display":"1,410,541.52","total_whole":"1,410,542","shares_owned_after":4536.0,"shares_owned_after_display":"4,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-09","filed_date":"2017-02-13","scope":"insider"},{"id":3185427,"accession":"0001209191-16-153407","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-153407","line_url":"/filing/0001209191-16-153407#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief, Bus. Ops & PAO)","role_mark":"O","role_mark_label":"Officer (Chief, Bus. Ops & PAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief, Bus. Ops & PAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4416.0,"shares_display":"4,416","price_per_share":20.7414,"price_display":"20.74","price_state":"stated","total_value":91594.0224,"total_display":"91,594.02","total_whole":"91,594","shares_owned_after":4536.0,"shares_owned_after_display":"4,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider"},{"id":2288878,"accession":"0001209191-16-145494","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-145494","line_url":"/filing/0001209191-16-145494#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief, Bus. Ops & PAO)","role_mark":"O","role_mark_label":"Officer (Chief, Bus. Ops & PAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief, Bus. Ops & PAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":20.82,"price_display":"20.82","price_state":"stated","total_value":5205.0,"total_display":"5,205.00","total_whole":"5,205","shares_owned_after":8952.0,"shares_owned_after_display":"8,952","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-07","filed_date":"2016-10-11","scope":"insider"},{"id":2997516,"accession":"0001209191-16-129447","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-129447","line_url":"/filing/0001209191-16-129447#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief of Business Operations)","role_mark":"O","role_mark_label":"Officer (Chief of Business Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief of Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":25.09,"price_display":"25.09","price_state":"stated","total_value":12545.0,"total_display":"12,545.00","total_whole":"12,545","shares_owned_after":9202.0,"shares_owned_after_display":"9,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-22","filed_date":"2016-06-24","scope":"insider"},{"id":8606234,"accession":"0001209191-15-086525","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-086525","line_url":"/filing/0001209191-15-086525","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief of Business Operations)","role_mark":"O","role_mark_label":"Officer (Chief of Business Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief of Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39026.0,"shares_display":"39,026","price_per_share":40.626454763491004,"price_display":"40.63","price_state":"stated","total_value":1585488.0236,"total_display":"1,585,488.02","total_whole":"1,585,488","shares_owned_after":9722.0,"shares_owned_after_display":"9,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-18","filed_date":"2015-12-22","scope":"insider","n_lines":2},{"id":8605709,"accession":"0001209191-15-083233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-083233","line_url":"/filing/0001209191-15-083233#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief of Business Operations)","role_mark":"O","role_mark_label":"Officer (Chief of Business Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief of Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7167.0,"shares_display":"7,167","price_per_share":38.0849,"price_display":"38.08","price_state":"stated","total_value":272954.4783,"total_display":"272,954.48","total_whole":"272,954","shares_owned_after":9202.0,"shares_owned_after_display":"9,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-01","filed_date":"2015-12-03","scope":"insider"},{"id":8886817,"accession":"0001209191-15-075006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-075006","line_url":"/filing/0001209191-15-075006#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief of Business Operations)","role_mark":"O","role_mark_label":"Officer (Chief of Business Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief of Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":29.82,"price_display":"29.82","price_state":"stated","total_value":7455.0,"total_display":"7,455.00","total_whole":"7,455","shares_owned_after":16369.0,"shares_owned_after_display":"16,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-07","filed_date":"2015-10-09","scope":"insider"},{"id":6207116,"accession":"0001209191-14-077399","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-077399","line_url":"/filing/0001209191-14-077399#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief of Business Operations)","role_mark":"O","role_mark_label":"Officer (Chief of Business Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief of Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27109.0,"shares_display":"27,109","price_per_share":40.1121,"price_display":"40.11","price_state":"stated","total_value":1087398.9189,"total_display":"1,087,398.92","total_whole":"1,087,399","shares_owned_after":11046.0,"shares_owned_after_display":"11,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-18","filed_date":"2014-12-22","scope":"insider"},{"id":7035838,"accession":"0001209191-14-072923","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-072923","line_url":"/filing/0001209191-14-072923#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief of Business Operations)","role_mark":"O","role_mark_label":"Officer (Chief of Business Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief of Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8898.0,"shares_display":"8,898","price_per_share":35.5994,"price_display":"35.60","price_state":"stated","total_value":316763.4612,"total_display":"316,763.46","total_whole":"316,763","shares_owned_after":11046.0,"shares_owned_after_display":"11,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-03","scope":"insider"},{"id":6976679,"accession":"0001209191-14-062643","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-062643","line_url":"/filing/0001209191-14-062643#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief of Business Operations)","role_mark":"O","role_mark_label":"Officer (Chief of Business Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief of Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":33.6,"price_display":"33.60","price_state":"stated","total_value":8400.0,"total_display":"8,400.00","total_whole":"8,400","shares_owned_after":19944.0,"shares_owned_after_display":"19,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-07","filed_date":"2014-10-09","scope":"insider"},{"id":4507650,"accession":"0001209191-13-055277","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-055277","line_url":"/filing/0001209191-13-055277#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief of Business Operations)","role_mark":"O","role_mark_label":"Officer (Chief of Business Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief of Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10836.0,"shares_display":"10,836","price_per_share":33.5125,"price_display":"33.51","price_state":"stated","total_value":363141.45,"total_display":"363,141.45","total_whole":"363,141","shares_owned_after":14194.0,"shares_owned_after_display":"14,194","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-04","scope":"insider"},{"id":3335808,"accession":"0001209191-12-055914","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-055914","line_url":"/filing/0001209191-12-055914#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9313.0,"shares_display":"9,313","price_per_share":24.2068,"price_display":"24.21","price_state":"stated","total_value":225437.9284,"total_display":"225,437.93","total_whole":"225,438","shares_owned_after":17936.0,"shares_owned_after_display":"17,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-03","filed_date":"2012-12-05","scope":"insider"},{"id":9086034,"accession":"0001209191-11-059456","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-059456","line_url":"/filing/0001209191-11-059456#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9896.0,"shares_display":"9,896","price_per_share":22.92,"price_display":"22.92","price_state":"stated","total_value":226816.32,"total_display":"226,816.32","total_whole":"226,816","shares_owned_after":16249.0,"shares_owned_after_display":"16,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-01","filed_date":"2011-12-05","scope":"insider"},{"id":7417816,"accession":"0001209191-10-058329","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-058329","line_url":"/filing/0001209191-10-058329","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10905.0,"shares_display":"10,905","price_per_share":26.537638697845026,"price_display":"26.54","price_state":"stated","total_value":289392.95,"total_display":"289,392.95","total_whole":"289,393","shares_owned_after":13645.0,"shares_owned_after_display":"13,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-01","filed_date":"2010-12-03","scope":"insider","n_lines":2},{"id":7654123,"accession":"0001209191-10-016605","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-016605","line_url":"/filing/0001209191-10-016605#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":34.1634,"price_display":"34.16","price_state":"stated","total_value":409960.8,"total_display":"409,960.80","total_whole":"409,961","shares_owned_after":10800.0,"shares_owned_after_display":"10,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-10","filed_date":"2010-03-12","scope":"insider"},{"id":7528004,"accession":"0001209191-10-006557","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-006557","line_url":"/filing/0001209191-10-006557#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":10800.0,"shares_owned_after_display":"10,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-02","filed_date":"2010-02-03","scope":"insider"},{"id":7689782,"accession":"0001209191-10-004831","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-004831","line_url":"/filing/0001209191-10-004831#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":140000.0,"total_display":"140,000.00","total_whole":"140,000","shares_owned_after":10800.0,"shares_owned_after_display":"10,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-22","filed_date":"2010-01-26","scope":"insider"},{"id":5886914,"accession":"0001209191-09-057660","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-057660","line_url":"/filing/0001209191-09-057660#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":24.484,"price_display":"24.48","price_state":"stated","total_value":122420.0,"total_display":"122,420.00","total_whole":"122,420","shares_owned_after":10800.0,"shares_owned_after_display":"10,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-16","filed_date":"2009-12-17","scope":"insider"},{"id":5729647,"accession":"0001209191-09-055043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-055043","line_url":"/filing/0001209191-09-055043#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7466.0,"shares_display":"7,466","price_per_share":24.5063,"price_display":"24.51","price_state":"stated","total_value":182964.0358,"total_display":"182,964.04","total_whole":"182,964","shares_owned_after":10800.0,"shares_owned_after_display":"10,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-01","filed_date":"2009-12-02","scope":"insider"},{"id":2947079,"accession":"0001209191-08-063864","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-063864","line_url":"/filing/0001209191-08-063864","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4134.0,"shares_display":"4,134","price_per_share":16.016608611514272,"price_display":"16.02","price_state":"stated","total_value":66212.66,"total_display":"66,212.66","total_whole":"66,213","shares_owned_after":8366.0,"shares_owned_after_display":"8,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-01","filed_date":"2008-12-03","scope":"insider","n_lines":2},{"id":3903730,"accession":"0001179110-08-012222","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001179110-08-012222","line_url":"/filing/0001179110-08-012222#line-25","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":31.67,"price_display":"31.67","price_state":"stated","total_value":31670.0,"total_display":"31,670.00","total_whole":"31,670","shares_owned_after":13700.0,"shares_owned_after_display":"13,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider"},{"id":3903729,"accession":"0001179110-08-012222","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001179110-08-012222","line_url":"/filing/0001179110-08-012222#line-24","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":31.66,"price_display":"31.66","price_state":"stated","total_value":28494.0,"total_display":"28,494.00","total_whole":"28,494","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider"},{"id":3903728,"accession":"0001179110-08-012222","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001179110-08-012222","line_url":"/filing/0001179110-08-012222#line-23","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":31.68,"price_display":"31.68","price_state":"stated","total_value":22176.0,"total_display":"22,176.00","total_whole":"22,176","shares_owned_after":13000.0,"shares_owned_after_display":"13,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider"},{"id":3903727,"accession":"0001179110-08-012222","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001179110-08-012222","line_url":"/filing/0001179110-08-012222#line-22","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":30.86,"price_display":"30.86","price_state":"stated","total_value":18516.0,"total_display":"18,516.00","total_whole":"18,516","shares_owned_after":18600.0,"shares_owned_after_display":"18,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider"},{"id":3903726,"accession":"0001179110-08-012222","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001179110-08-012222","line_url":"/filing/0001179110-08-012222#line-21","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":31.58,"price_display":"31.58","price_state":"stated","total_value":15790.0,"total_display":"15,790.00","total_whole":"15,790","shares_owned_after":17300.0,"shares_owned_after_display":"17,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider"},{"id":3903725,"accession":"0001179110-08-012222","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001179110-08-012222","line_url":"/filing/0001179110-08-012222#line-20","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":31.69,"price_display":"31.69","price_state":"stated","total_value":12676.0,"total_display":"12,676.00","total_whole":"12,676","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider"},{"id":3903724,"accession":"0001179110-08-012222","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001179110-08-012222","line_url":"/filing/0001179110-08-012222#line-19","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":31.6,"price_display":"31.60","price_state":"stated","total_value":12640.0,"total_display":"12,640.00","total_whole":"12,640","shares_owned_after":16500.0,"shares_owned_after_display":"16,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider"},{"id":3903723,"accession":"0001179110-08-012222","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001179110-08-012222","line_url":"/filing/0001179110-08-012222#line-18","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":31.59,"price_display":"31.59","price_state":"stated","total_value":9477.0,"total_display":"9,477.00","total_whole":"9,477","shares_owned_after":16900.0,"shares_owned_after_display":"16,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider"},{"id":3903722,"accession":"0001179110-08-012222","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001179110-08-012222","line_url":"/filing/0001179110-08-012222#line-17","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":31.575,"price_display":"31.58","price_state":"stated","total_value":9472.5,"total_display":"9,472.50","total_whole":"9,473","shares_owned_after":18000.0,"shares_owned_after_display":"18,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider"},{"id":3903721,"accession":"0001179110-08-012222","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001179110-08-012222","line_url":"/filing/0001179110-08-012222#line-16","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":31.655,"price_display":"31.66","price_state":"stated","total_value":6331.0,"total_display":"6,331.00","total_whole":"6,331","shares_owned_after":15900.0,"shares_owned_after_display":"15,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider"},{"id":3903720,"accession":"0001179110-08-012222","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001179110-08-012222","line_url":"/filing/0001179110-08-012222#line-15","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272353","owner_name":"LAWRENCE DAVID","owner_display_name":"LAWRENCE DAVID","owner_url":"/insider/0001272353","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":31.65,"price_display":"31.65","price_state":"stated","total_value":6330.0,"total_display":"6,330.00","total_whole":"6,330","shares_owned_after":16100.0,"shares_owned_after_display":"16,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider"}],"collapsed":true,"next_cursor":"2008-06-12|3903720","ledger_fault":false,"count":{"value":312,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":312,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":312},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001008848","name":"ACORDA THERAPEUTICS INC","url":"/issuer/0001008848","role":"Officer (Chief, Bus. Ops & PAO)","n_filings":54,"first_seen":"2006-11-08","last_seen":"2019-12-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001272353","retrieved_at":"2026-08-27T01:16:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}